Search for: "CIPLA USA, INC."
Results 1 - 20
of 29
Sorted by Relevance
|
Sort by Date
13 Feb 2014, 9:04 am
Indianapolis, Indiana - Indiana patent lawyers for Alcon Research, LTD of Fort Worth, Texas and Alcon Pharmaceuticals Ltd of Fribourg, Switzerland (collectively, "Alcon") sued in the Southern District of Indiana alleging that Cipla Limited of Mumbai Central, Mumbai and Cipla USA Inc. of Miami, Florida (collectively, "Cipla") infringed Olopatadine Formulations for Topical Administration, Patent Nos. 6,995,186 (the "'186 patent") and 7,402,609 (the "'609… [read post]
23 Apr 2014, 9:59 pm
Cipla Ltd. et al. 1:14-cv-00427; filed April 7, 2014 in the District Court of Delaware • Plaintiffs: Helsinn Healthcare S.A.; Roche Palo Alto LLC • Defendants: Cipla Ltd.; Cipla USA Inc. [read post]
6 Sep 2007, 12:33 pm
” Signtech USA, Ltd. v. [read post]
31 Oct 2016, 11:33 am
This federal lawsuit, commenced in the Southern District of Indiana, lists two Defendants, Cipla Limited of Mumbai, India and its wholly owned subsidiary Cipla USA, Inc. of Miami, Florida. [read post]
4 Dec 2013, 7:06 am
Huawei Device USA Inc. and Futurewei Technologies, Inc. [read post]
3 Apr 2017, 2:22 pm
Cipla Ltd., 681 F.3d 1283, 1304–05 (Fed. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
18 Mar 2010, 2:30 am
Teva Pharmaceuticals USA, Inc. et al. and Gilead Sciences, Inc., et al. v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
22 Apr 2010, 3:51 am
Paddock Laboratories, Inc. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy': (IP… [read post]
14 Dec 2007, 1:00 am
Gore & Associates Inc. held to have willfully infringed rival C.R. [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and… [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva Pharma… [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
